Treatment of benign bone lesions with an injectable bone filler material

Not Applicable

Completed

• Conditions: Benign bone lesions; Musculoskeletal Diseases

• Registration Number: ISRCTN10903007
• Lead Sponsor: Medical University of Vienna

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-03-27
• Study Start: 2022-07-21
• Last Update Posted: 5 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Patients who:
1. Received treatment with a ceramic biphasic bone substitute
2. For benign bone tumors and tumor-like lesions
3. With a complete set of retrospective information, including surgical protocols, X-rays, patient dismission letters and outpatient clinic protocols
4. With a minimum follow-up of 1 year after surgery

Exclusion Criteria

1. Inconclusive data with missing surgical or histological reports

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ocal recurrences identified by retrospective analysis of patient charts in the timeframe between surgery and last follow-up at the outpatient clinic

Secondary Outcome Measures

Name	Time	Method
1. Postoperative cavity morphology changes assessed using x-rays at 6 weeks, 3 months, 6 months, 12 months, 18 months and at the last follow-up after surgery (MRI will be assessed in cases of suspected recurrence or incomplete cavity consolidation)<br>3. Postoperative complications assessed by review of patient charts in the timeframe between surgery and last follow-up at the outpatient clinic